Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01087281 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Top-Down Attentional Control of Visual-Processing

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 360 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor 32 versions Re-verified since Oct 29, 2025, no change to tracked fieldsv329-v360
  2. Minor Eligibility criteria revisedv328
  3. Minor 6 versions Re-verified since Jul 31, 2025, no change to tracked fieldsv322-v327
  4. Notable Enrollment target: 132 to 300v321
  5. Minor 2 versions Re-verified since Jun 27, 2025, no change to tracked fieldsv319-v320
Show 8 earlier versionsHide 8 earlier versions
  1. Minor Eligibility criteria shortened, about 20 wordsv318
  2. Minor 7 versions Re-verified since Apr 22, 2025, no change to tracked fieldsv311-v317
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: \- Previous studies have shown that people with certain types of brain damage may have particular problems paying attention and processing things that they see. Researchers are interested in comparing how people with brain damage and without brain damage process visual images. Objectives: \- To better understand the areas of the brain involved in paying attention to things that are seen. Eligibility: \- Individuals at least 18 years of age who either have had damage to one or both sides of specific parts of the brain (e.g., stroke, injury, certain neurosurgery procedures) or are healthy volunteers. Design: * The study involves 4 to 10 visits to the NIH Clinical Center over 1 to 2 years. Each visit will last approximately 2 hours. * Participants will be screened with a medical history and physical examination, and may have the cognitive testing described below during the same visit. * On the first visit and for at least one visit thereafter, participants will have cognitive testing to evaluate thinking and memory. These tests will be either written tests or computer-based tests. * Some participants will qualify for functional magnetic resonance imaging (fMRI) as part of the study. This part will involve a decision-making task that will be performed on a computer during the fMRI scan. Additional scans may be required as directed by the study doctors. * Some randomly selected participants will be asked to have magnetoencephalography (MEG), a procedure to record very small magnetic field changes produced by brain activity. * During the behavioral training, or fMRI or MEG scanning, participants may be monitored with equipment to track eye movements.
Trial Details
NCT Number NCT01087281
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions
(from sponsor)
Focal Brain Lesion, Focal Lesions, fMRI
Related terms Nervous System Diseases
Enrollment 300 participants
Start Date
Updated on ClinicalTrials.gov